Editor-in-Chief
- John B. Haanen – Amsterdam, The Netherlands
Senior Editors
- George Coukos – Lausanne, Switzerland
Section Editors
Neoantigens, tumour-infiltrating lymphocytes
- Michal Bassani – Lausanne, Switzerland
Cell therapies and cytokines
- Alena Gros – Barcelona, Spain
Adoptive cell therapy and gene therapy
- Johanna Olweus – Oslo, Norway
T cell diagnostics and isolation platforms
- Sine Reker Hadrup – Copenhagen, Denmark
Genomics, tumor mutational burden, tumor heterogeneity
- Samra Turajlic - London, UK
Nanoparticles
- Li Tang – Lausanne, Switzerland
Biomarkers and novel IO targets
- Daniela Thommen – Amsterdam, Netherlands
Social Media Editor
- Jonathon Lim – London, UK
Board members
- Alberto Bardelli – Candiolo, Italy
- Tim Chan – New York, USA
- Charles C. Drake - New York, USA
- David Gfeller – Lausanne, Switzerland
- Siwen Hu-Lieskovan – Salt Lake City, USA
- Keith Kerr – Aberdeen, UK
- Sebastian Kobold – München, Germany
- Arthur M. Krieg - Cambridge, USA
- Aurelien Marabelle - Paris, France
- Alexander Menzies – Sydney, Australia
- Michael Milone - Philadephia, USA
- Thomas Powles – London, UK
- Antoni Ribas – Los Angeles, USA
- Padmanee Sharma – Houston, Texas
- Daniel E. Speiser – Lausanne, Switzerland
- Charles Swanton – London, UK
- Michele Teng – Brisbane, Australia
- Jennifer J. Wargo – Houston, USA
- Anna M. Wu – Duarte, USA
Last update: September 2022